Analysts expect Moderna, Inc. to report revenue of 942.59 M for Q3 26, against a range of 903.37 M to 981.81 M. The most recent reported quarter, Q2 26, came in at 145.00 M, a 48.5% beat against the 97.61 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.86 B | 966.00 M | 108.00 M | 142.00 M | 1.02 B | 678.00 M | 389.00 M | 145.00 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.39 B | 1.06 B | 118.37 M | 107.93 M | 1.01 B | 662.22 M | 237.41 M | 100.54 M | 981.81 M | 746.31 M | 306.86 M | 134.96 M | 1.12 B | 1.00 B | 491.84 M | 250.82 M | ||||||||||
| Low Estimate | 1.19 B | 871.78 M | 106.72 M | 99.92 M | 917.34 M | 577.74 M | 211.33 M | 94.68 M | 903.37 M | 641.33 M | 251.24 M | 116.58 M | 978.10 M | 883.72 M | 450.41 M | 213.51 M | ||||||||||
| Consensus Estimate | 1.29 B | 965.59 M | 112.54 M | 103.92 M | 964.26 M | 619.98 M | 224.37 M | 97.61 M | 942.59 M | 693.82 M | 279.05 M | 125.77 M | 1.05 B | 942.51 M | 471.13 M | 232.17 M |
Analysts expect Moderna, Inc. to report earnings per share of -1.07 for Q3 26, against a range of -1.12 to -1.02. The most recent reported quarter, Q2 26, came in at -1.97, a 5.7% beat against the -2.09 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.03 | -2.91 | -2.52 | -2.13 | -0.51 | -2.11 | -3.40 | -1.97 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.53 | -2.63 | -2.71 | -2.93 | -1.68 | -2.38 | -4.13 | -1.91 | -1.02 | -1.55 | -1.62 | -1.74 | -0.54 | -0.71 | -0.93 | -1.08 | ||||||||||
| Low Estimate | -1.87 | -2.87 | -3.23 | -3.25 | -1.86 | -2.88 | -4.43 | -2.27 | -1.12 | -1.69 | -1.88 | -2.02 | -0.60 | -0.79 | -1.09 | -1.22 | ||||||||||
| Consensus Estimate | -1.70 | -2.75 | -2.97 | -3.09 | -1.77 | -2.63 | -4.28 | -2.09 | -1.07 | -1.62 | -1.75 | -1.88 | -0.57 | -0.75 | -1.01 | -1.15 |
Pull Wall Street consensus for Moderna, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MRNA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MRNA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MRNA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();